Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma

Sponsor
National Cancer Institute (NCI) (NIH)
Overall Status
Completed
CT.gov ID
NCT00341952
Collaborator
(none)
2,378
4
108.1
594.5
5.5

Study Details

Study Description

Brief Summary

Non-Hodgkin's lymphoma (NHL) incidence rates have risen three percent per year in the U.S. for four decades. Mortality from NHL has risen 1.6 percent, compared with 0.2 percent for all cancers combined. This epidemic curve appears in both sexes and around the world, suggesting the possibility of an etiologic agent increasing in prevalence in the general environment. Recent research has identified several possible candidates including pesticides, other organochlorines, drinking water nitrates, and sunlight. There is an urgent need to evaluate whether these common exposures are contributing to the rapid rise in NHL, and to investigate other hypothesized risk factors such as viruses, medical conditions, hair dye use, and genetic factors. The purpose of this study is to examine the contribution to NHL risk of these important environmental, occupational, viral, medical, and personal exposures, and to pursue important leads emerging from on-going NHL research. This multidisciplinary, population-based case-control study will involve personal interviews to collect information on demographics, residential history, pesticide use, and occupational exposures; self-administered questionnaires to collect information on diet, family and medical history, and other exposures; tap water and carpet dust sampling to collect information on nitrate and pesticide exposures; and blood sampling for measurements of compounds in the serum, antibodies to viruses, and examination of genetic polymorphisms.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Non-Hodgkin's lymphoma (NHL) incidence rates have risen three percent per year in the U.S. for four decades. Mortality from NHL has risen 1.6 percent, compared with 0.2 percent for all cancers combined. This epidemic curve appears in both sexes and around the world, suggesting the possibility of an etiologic agent increasing in prevalence in the general environment. Recent research has identified several possible candidates including pesticides, other organochlorines, drinking water nitrates, and sunlight. There is an urgent need to evaluate whether these common exposures are contributing to the rapid rise in NHL, and to investigate other hypothesized risk factors such as viruses, medical conditions, hair dye use, and genetic factors. The purpose of this study is to examine the contribution to NHL risk of these important environmental, occupational, viral, medical, and personal exposures, and to pursue important leads emerging from on-going NHL research. This multidisciplinary, population-based case-control study will involve personal interviews to collect information on demographics, residential history, pesticide use, and occupational exposures; self-administered questionnaires to collect information on diet, family and medical history, and other exposures; tap water and carpet dust sampling to collect information on nitrate and pesticide exposures; and blood sampling for measurements of compounds in the serum, antibodies to viruses, and examination of genetic polymorphisms.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    2378 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma
    Study Start Date :
    Apr 15, 1998
    Actual Primary Completion Date :
    Apr 17, 2007
    Actual Study Completion Date :
    Apr 17, 2007

    Arms and Interventions

    Arm Intervention/Treatment
    Cases

    individuals diagnosed with incident, first primary non-Hodgkin lymphoma

    Controls

    individuals identified in the same geographical areas without non-Hodgkin lymphoma or othercancers

    Outcome Measures

    Primary Outcome Measures

    1. No intervention. Observational study compares cases and controls. [at the time of enrollment]

      non-Hodgkin lymphoma cases versus controls

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 74 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    • ELIGIBILITY CRITERIA:

    Women and men residing in the areas served by the four SEER registries.

    Individuals between the ages of 20 and 74 (ages between 20 and 64 must live in households with telephones).

    Individuals who have a first primary diagnosis of NHL after April 1, 1998 to July 1, 1998.

    Individuals must be HIV negative.

    EXCLUSION CRITERIA:

    Individuals must not be previously diagnosed with NHL.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Southern California Los Angeles California United States 90033
    2 University of Iowa Iowa City Iowa United States 52242
    3 Wayne State University Hutzel Hospital Detroit Michigan United States 48201
    4 University of Washington Seattle Washington United States 98195

    Sponsors and Collaborators

    • National Cancer Institute (NCI)

    Investigators

    • Principal Investigator: Nathaniel Rothman, M.D., National Cancer Institute (NCI)

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    National Cancer Institute (NCI)
    ClinicalTrials.gov Identifier:
    NCT00341952
    Other Study ID Numbers:
    • 999998022
    • OH98-C-N022
    First Posted:
    Jun 21, 2006
    Last Update Posted:
    Nov 27, 2020
    Last Verified:
    Nov 1, 2020
    Keywords provided by National Cancer Institute (NCI)
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 27, 2020